Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab emtansine), IgG1
Artikelnummer:
SYB-CHB279
Produktübersicht
Artikelname:
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab emtansine), IgG1
Artikelnummer:
SYB-CHB279
Hersteller Artikelnummer:
CHB279
Alternativnummer:
SYB-CHB279-100UG,SYB-CHB279-1MG
Hersteller:
Sanyou Bio
Kategorie:
Antikörper
Applikation:
ELISA, FA, FACS, Kinetics
Spezies Reaktivität:
Human
Produktbeschreibung
Trastuzumab emtansine is an ADC consisting of a HER2-directed antibody and DM1, a potent derivative of maytansine, used for the study of advanced breast cancer.
Produkteigenschaften
Konzentration:
1mg/ml
Molekulargewicht:
145 kDa
Isotyp:
IgG1
NCBI:
04626
Puffer:
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Reinheit:
>90%
Formulierung:
Lyophilized
Target-Kategorie:
ERBB2 / HER2 / CD340